MediciNova
MNOV
30 hedge funds and large institutions have $7.4M invested in MediciNova in 2026 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 7 closing their positions.
0.28% more ownership
Funds ownership: 10.7% → 10.98% (+0.28%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4% less capital invested
Capital invested by funds: $7.7M → $7.4M (-$299K)
9% less funds holding
Funds holding: 33 → 30 (-3)
11% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 9
29% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Barclays
London,
United Kingdom
|
+$187K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$32.1K |
| 3 |
JP Morgan Chase
New York
|
+$30.3K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$21.6K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$21.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DS
DRW Securities
Chicago,
Illinois
|
-$821K |
| 2 |
Jane Street
New York
|
-$115K |
| 3 |
LWA
Lantern Wealth Advisors
Melville,
New York
|
-$39.3K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$37.6K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$30.3K |
MNOV Hedge Fund Activity: Q1 2026 in Review
30 of the 8,206 institutional investors tracked by Wall St. Rank reported a position in MediciNova (MNOV) for Q1 2026, worth a combined $7.4M — down 3.9% from $7.7M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of MNOV and 5 opened new positions — a net loss of 2 holders — while 9 trimmed existing stakes and 8 added.
The largest buyer was Barclays, adding an estimated $187K. The largest seller was DRW Securities, exiting entirely with an estimated $821K sold.
- 30 institutional investors held MediciNova (MNOV) as of Q1 2026, down from 33 in Q4 2025.
- Funds reported $7.4M of MediciNova stock for Q1 2026, down 3.9% quarter-over-quarter.
- 5 funds opened new MediciNova positions in Q1 2026 and 7 closed out, a net change of -2 holders.
- The largest MediciNova buyer in Q1 2026 was Barclays, an estimated $187K added.
- The largest MediciNova seller in Q1 2026 was DRW Securities, an estimated $821K sold.
Based on aggregated 13F filings for Q1 2026.